Are plasma soluble intercellular adhesion molecule 1 levels increased in type 2 diabetic patients with nephropathy?
The plasma sICAM-1 levels in patients with type 2 diabetes mellitus are not significantly different from those in nondiabetic subjects. High levels of sICAM-1 suggest that sICAM-1 may play a role in the development of nephropathy in patients with type 2 diabetes mellitus.
Formononetin may be developed as a antioxidant drug to treat diabetic retinopathy.